Bristol-Myers Squibb Company
BMY
$48.46
$0.561.17%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.64B | 48.30B | 47.44B | 46.51B | 45.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.64B | 48.30B | 47.44B | 46.51B | 45.53B |
| Cost of Revenue | 12.06B | 11.95B | 11.44B | 11.08B | 10.92B |
| Gross Profit | 35.58B | 36.35B | 35.99B | 35.43B | 34.62B |
| SG&A Expenses | 7.43B | 7.82B | 8.03B | 7.89B | 7.88B |
| Depreciation & Amortization | 7.35B | 8.87B | 9.46B | 9.31B | 9.15B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.51B | 38.42B | 38.40B | 37.57B | 37.20B |
| Operating Income | 11.13B | 9.88B | 9.03B | 8.94B | 8.33B |
| Income Before Tax | 6.11B | -8.38B | -6.88B | -6.42B | -5.85B |
| Income Tax Expenses | 671.00M | 554.00M | 367.00M | 109.00M | 289.00M |
| Earnings from Continuing Operations | 5.44K | -8.93K | -7.25K | -6.53K | -6.14K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -18.00M | -15.00M | -11.00M | -13.00M | -13.00M |
| Net Income | 5.42B | -8.95B | -7.26B | -6.54B | -6.15B |
| EBIT | 11.13B | 9.88B | 9.03B | 8.94B | 8.33B |
| EBITDA | 18.89B | 19.52B | 19.28B | 19.02B | 18.24B |
| EPS Basic | 2.67 | -4.43 | -3.59 | -3.25 | -3.09 |
| Normalized Basic EPS | 3.43 | 3.05 | 3.02 | 3.07 | 2.95 |
| EPS Diluted | 2.66 | -4.43 | -3.60 | -3.26 | -3.10 |
| Normalized Diluted EPS | 3.42 | 3.04 | 3.02 | 3.07 | 2.94 |
| Average Basic Shares Outstanding | 8.12B | 8.11B | 8.11B | 8.13B | 8.20B |
| Average Diluted Shares Outstanding | 8.14B | 8.12B | 8.12B | 8.15B | 8.22B |
| Dividend Per Share | 2.44 | 2.42 | 2.40 | 2.37 | 2.34 |
| Payout Ratio | 90.59% | -54.35% | -66.20% | -73.08% | -77.42% |